Patents by Inventor Rosanne Orr

Rosanne Orr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Materials and Methods for Treatment of Cancer
    Publication number: 20110123998
    Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumours which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.
    Type: Application
    Filed: November 17, 2010
    Publication date: May 26, 2011
    Inventors: Janet Shipley, Daniel Williamson, Jane Renshaw, Rosanne Orr
  • Materials and methods for treatment of cancer
    Patent number: 7855182
    Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumors which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: December 21, 2010
    Assignee: The Institute of Cancer Research; Royal Cancer Hospital
    Inventors: Janet Shipley, Daniel Williamson, Jane Renshaw, Rosanne Orr
  • Materials and Methods for Treatment of Cancer
    Publication number: 20080241825
    Abstract: Glypican 5 is shown for the first time to have a role in proliferation of cancer cells, including tumours which do not show chromosomal amplification at 13q31. The use of glypican 5 (GPC5) antagonists and binding agents for the treatment of cancer, particularly rhabdomyosarcoma and breast cancer, is disclosed.
    Type: Application
    Filed: March 22, 2005
    Publication date: October 2, 2008
    Applicant: THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL
    Inventors: Janet Shipley, Daniel Williamson, Jane Renshaw, Rosanne Orr